European Off-Patent Industry Decries Price Cuts And Clawbacks
Medicines for Europe Calls For Pricing And Reimbursement Reform
Executive Summary
A Medicines for Europe report on policies affecting the off-patent industry across 22 European countries aims to demonstrate the urgent need for pricing and reimbursement and procurement reforms.